Defining primary bile acid diarrhea: Making the diagnosis and recognizing the disorder

Expert Review of Gastroenterology and Hepatology

Volumn 4, Issue 5, 2010, Pages 561-567

  Walters, Julian R F ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

bile salts; chronic diarrhea; enterohepatic circulation; FGF19; IBS; ileum; malabsorption; SeHCAT

Indexed keywords

BILE ACID; FIBROBLAST GROWTH FACTOR 19; TAUROSELCHOLIC ACID SE 75;

BILE ACID METABOLISM; BILE ACID SYNTHESIS; DIARRHEA; FEEDBACK SYSTEM; HORMONE ACTION; HORMONE RELEASE; HUMAN; IDIOPATHIC DISEASE; MALABSORPTION; PATHOPHYSIOLOGY; PATIENT IDENTIFICATION; REVIEW;

BILE ACIDS AND SALTS; BIOLOGICAL MARKERS; CHOLESTENONES; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; ENTEROHEPATIC CIRCULATION; FIBROBLAST GROWTH FACTORS; HUMANS; MALABSORPTION SYNDROMES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; TAUROCHOLIC ACID;

EID: 77958027847     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.10.54     Document Type: Review

References (51)

1. Hofmann AF. The syndrome of ileal disease and the broken enterohepatic circulation: Cholerheic enteropathy. Gastroenterology 52(4), 752-757 (1967). Key description of bile acid-induced diarrhea.
2. Hofmann AF. Bile acids: Trying to understand their chemistry and biology with the hope of helping patients. Hepatology 49(5), 1403-1418 (2009).
3. Westergaard H. Bile acid malabsorption. Curr. Treat. Options Gastroenterol. 10(1), 28-33 (2007).
4. Fromm H, Hofmann AF. Breath test for altered bile-acid metabolism. Lancet 2(7725), 621-625 (1971).
5. Boyd GS, Merrick MV, Monks R, Thomas IL. Se-75-labeled bile acid analogs, new radiopharmaceuticals for investigating the enterohepatic circulation. J. Nucl. Med. 22(8), 720-725 (1981).
6. Merrick MV, Eastwood MA, Ford MJ. Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis by measurement of SeHCAT retention. Br. Med. J. (Clin. Res. Ed.) 290(6469), 665-668 (1985).
7. Sciarretta G, Fagioli G, Furno A et al. 75SeHCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. Gut 28(8), 970-975 (1987).
8. Ford GA, Preece JD, Davies IH, Wilkinson SP. Use of the SeHCAT test in the investigation of diarrhoea. Postgrad. Med. J. 68(798), 272-276 (1992).
9. Williams AJK, Merrick MV, Eastwood MA. Idiopathic bile acid malabsorption - a review of clinical presentation, diagnosis, and response to treatment. Gut 32, 1004-1006 (1991).
10. Nyhlin H, Merrick MV, Eastwood MA. Bile acid malabsorption in Crohn's disease and indications for its assessment using SeHCAT. Gut 35, 90-93 (1994).
11. Smith MJ, Cherian P, Raju GS, Dawson BF, Mahon S, Bardhan KD. Bile acid malabsorption in persistent diarrhoea. J. R. Coll. Physicians (Lond.) 34, 448-451 (2000). One of several papers studying the frequency of abnormal 75Se-homocholyltaurine (SeHCAT) tests in patients with various conditions producing chronic diarrhea.
12. Wildt S, Rasmussen SN, Madsen JL, Rumessen JJ. Bile acid malabsorption in patients with chronic diarrhoea: Clinical value of SeHCAT test. Scand. J. Gastroenterol. 38, 826-830 (2003).
13. Thaysen EH, Pedersen L. Diarrhoea associated with idiopathic bile acid malabsorption. Fact or fantasy? Dan. Med. Bull. 20(6), 174-177 (1973).
14. Thaysen EH, Pedersen L. Idiopathic bile acid catharsis. Gut 17(12), 965-970 (1976). Descriptions of patients with primary bile acid diarrhea.
15. Fromm H, Malavolti M. Bile acid induced diarrhoea. Clin. Gastroenterol. 15, 567-582 (1986).
16. Wedlake L, A'Hern R, Thomas K, Walters JRF, Andreyev HJN. Systematic review: The prevalence of idiopathic bile acid malabsorption (I-BAM) as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome (IBS). Aliment Pharmacol. Ther. 30, 707-717 (2009). Review summarizing the prevalence of primary bile acid diarrhea, as shown in 18 studies and over 1000 patients.
17. Ford AC. Applicability of the reported prevalence of bile salt malabsorption in irritable bowel. Aliment Pharmacol. Ther. 31(1), 161-162 (2010).
18. Khalid U, Lalji A, Stafferton R, Andreyev J. Bile acid malabsorption: A forgotten diagnosis? Clin. Medicine 10(2), 124-126 (2010).
19. Brydon WG, Nyhlin H, Eastwood MA, Merrick MV. Serum 7 α-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea. Eur. J. Gastroenterol. Hepatol. 8(2), 117-123 (1996). Validation of C4 and SeHCAT in bile acid-induced diarrhea.
20. Sauter GH, Munzing W, von Rilter C, Paumgartner G. Bile acid malabsorption as a cause of chronic diarrhea: Diagnostic value of 7α-hydroxy-4-cholesten-3-one in serum. Dig. Dis. Sci. 44(1), 14-19 (1999).
21. Camilleri M, Nadeau A, Tremaine WJ et al. Measurement of serum 7 α-hydroxy-4-cholesten-3-one (or 7 αC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol. Motil. 21(7), 734-e43 (2009).
22. Fernandez-Banares F, Esteve M, Salas A et al. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am. J. Gastroenterol. 102(11), 2520-2528 (2007). Bile acid diarrhea was found to be the most common cause of functional diarrhea.
23. Fan X, Sellin JH. Small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea. Aliment. Pharmacol. Ther. 29(10), 1069-1077 (2009).
24. Spiller RC, Thompson WG. Bowel disorders. Am. J. Gastroenterol. 105(4), 775-785 (2010).
25. Thomas PD, Forbes A, Green J et al. Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut 52(Suppl. 5), v1-v15 (2003).
26. Williams JG, Roberts SE, Ali MF et al. Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: A review of the evidence. Gut 56(Suppl. 1), 1-113 (2007).
27. Leeds JS, Hopper AD, Sanders DS. Coeliac disease. Br. Med. Bull. 88(1), 157-170 (2008).
28. Richey R, Howdle P, Shaw E, Stokes T. Recognition and assessment of coeliac disease in children and adults: Summary of NICE guidance. BMJ 338, b1684 (2009).
29. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 102(1), 330-354 (1992).
30. Hiatt JG, Shamsie SG, Schectman G. Discontinuation rates of cholesterol-lowering medications: Implications for primary care. Am. J. Manag. Care 5(4), 437-444 (1999).
31. Rossel P, Sortsoe JH, Qvist P, Arveschoug A. Prognosis of adult-onset idiopathic bile acid malabsorption. Scand. J. Gastroenterol. 34(6), 587-590 (1999).
32. Wedlake L, Thomas K, Lalji A, Anagnostopoulos C, Andreyev HJN. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: A retrospective chart review and patient questionnaire. Clin. Therap. 31(11), 2549-2558 (2009).
33. Walters JRF, Pattni SS. Managing bile acid diarrhoea. Therap. Adv. Gastroenterol. (2010) (In press).
34. Sollid LM, Khosla C. Future therapeutic options for celiac disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2(3), 140-147 (2005).
35. Bajor A, Kilander A, Galman C, Rudling M, Ung KA. Budesonide treatment is associated with increased bile acid absorption in collagenous colitis. Aliment. Pharmacol. Ther. 24(11-12), 1643-1649 (2006).
36. Ung KA, Gillberg R, Kilander A, Abrahamsson H. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut 46(2), 170-175 (2000).
37. van Tilburg AJ, de Rooij FW, van den Berg JW, van Blankenstein M. Primary bile acid diarrhoea without an ileal carrier defect: Quantification of active bile acid transport across the ileal brush border membrane. Gut 32(5), 500-503 (1991).
38. Bajor A, Kilander A, Fae A et al. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. Eur. J. Gastroenterol. Hepatol. 18(4), 397-403 (2006).
39. van Tilburg AJ, de Rooij FW, van den Berg JW, van Blankenstein M. Primary bile acid malabsorption: A pathophysiologic and clinical entity? Scand. J. Gastroenterol. Suppl. 194, 66-70 (1992). Key paper demonstrating increased bile acid pool size and questioning whether any malabsorption existed in primary bile acid diarrhea.
40. Oelkers P, Kirby LC, Heubi JE, Dawson PA. Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). J. Clin. Invest. 99, 1880-1887 (1997).
41. Montagnani M, Love MW, Rössel P, Dawson PA, Qvist P. Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption. Scand J. Gastroenterol. 36, 1077-1080 (2001).
42. Montagnani M, Abrahamsson A, Galman C et al. Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption. World J. Gastroenterol. 12(47), 7710-7714 (2006).
43. Balesaria S, Pell RJ, Abbott LJ et al. Exploring possible mechanisms for primary bile acid malabsorption: Evidence for different regulation of ileal bile acid transporter transcripts in chronic diarrhoea. Eur. J. Gastroenterol. Hepatol. 20(5), 413-422 (2008).
44. Bajor A, Ung KA, Ohman L et al. Indirect evidence for increased mechanosensitivity of jejunal secretomotor neurones in patients with idiopathic bile acid malabsorption. Acta Physiol. (Oxf.) 197, 129-137 (2009).
45. Walters JRF, Tasleem AM, Omer OS, Brydon WG, Dew T, Le Roux CW. A new mechanism for bile acid diarrhea: Defective feedback inhibition of bile acid biosynthesis. Clin. Gastro. Hepatol. 7, 1189-1194 (2009). Reduced levels of FGF19 suggest a new mechanism with increased bile acid synthesis.
46. Inagaki T, Choi M, Moschetta A et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell. Metab. 2(4), 217-225 (2005). Detailed description of the effects of FGF15 on bile acid metabolism in the mouse.
47. Inagaki T, Moschetta A, Lee YK et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc. Natl Acad. Sci. USA 103(10), 3920-3925 (2006).
48. Lundasen T, Galman C, Angelin B, Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J. Intern. Med. 260(6), 530-536 (2006).
49. Odunsi-Shiyanbade ST, Camilleri M, McKinzie S et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin. Gastroenterol. Hepatol. 8(2), 159-165 (2010).
50. Tomiyama K, Maeda R, Urakawa I et al. Relevant use of Klotho in FGF19 subfamily signaling system in vivo. Proc. Natl Acad. Sci. USA 107(4), 1666-1671 (2010).
51. Hofmann AF. Chronic diarrhea caused by idiopathic bile acid malabsorption: An explanation at last. Expert Rev.Gastroenterol. Hepatol. 3(5), 461-464 (2009).